Solagran is slowly showing it's true value. Up over 30% today on after sucessfull Phase 2 trials. Still way undervalued in my opinion and I expect we will see some major players taking some interest in Solagran in the near future.
I hold SLA
SLA Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held